patent.fyi
Applications  /  US 2026/0354770
United States Patent Application Publication

US 2026/0354770 A1

Published
Nov 12, 2026
Filed
Apr 16, 2026
Earliest date on the face
Mar 15, 2013
Classification
A61B 5/7275
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Glucose sensing in blood

What ifWhat if the sensor measured glucose directly in venous blood?
Claim language“in interstitial fluid”

A venous catheter contains an amperometric glucose electrode that contacts circulating blood. A potentiostat measures electrode current, and the acquisition circuit converts it to a timestamped glucose reading once per minute.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Glucose rise tracking in fermentation

An inline enzymatic glucose probe measures dissolved glucose in a stirred fermentation vessel and sends timestamped readings to a local process computer. The detector stores the median of the five readings before the first reading that sits at least 0.3 grams per liter above that median, then confirms the episode when the next two readings also exceed the stored median by that amount. The display marks the first reading in the episode and labels it with the most recent feed pump start in the preceding 20 minutes when the pump log contains a matching event.

Component substitution

Inductive readout for glucose data

An inductive load-modulation link carries readings from a skin-worn interstitial glucose sensor to a handheld reader. A coil in the reader supplies the carrier field, and a coupled coil in the sensor module returns stored readings with their acquisition timestamps when the reader is brought near the module. The reader checks packet integrity, reconstructs the time series, and marks the first point in a sustained rise on its display. It labels the marker with the most recent hydration entry when that entry falls within the configured interval before onset.

Parameter or scale variation

Seven day view with persistence checks

An interstitial glucose sensor sends one timestamped reading per minute to a handheld display that plots a rolling seven-day trace. Each reading that exceeds the median of the preceding 20 readings by at least 15 milligrams per deciliter starts a candidate episode and fixes that median as the baseline. The processor confirms the episode when the next 11 consecutive one-minute readings also exceed that baseline by at least 15 milligrams per deciliter, and it marks the candidate's first reading as the onset. The display labels the onset with the latest logged sleep or wake transition within the preceding 90 minutes when such an entry exists.

Combination with existing systems

Glucose episodes on a sleep timeline

A wrist actigraphy system estimates sleep onset and waking from wrist motion and exports timestamped sleep transitions to the glucose display application. The application aligns those timestamps with the interstitial glucose readings and detects sustained upward shifts from a pre-episode glucose baseline. It draws sleep intervals behind the glucose trace and attaches the most recent waking marker to a detected episode when waking precedes the episode onset by 5 to 60 minutes.

Automated or data-driven variant

Change point detection with adaptive noise

A local processor estimates the glucose baseline and noise level from the median and median absolute deviation of a rolling 30-minute window. An upper cumulative sum detector accumulates positive deviations from the baseline after subtracting a noise allowance, and it resets the sum to zero when the result would be negative. The processor holds the baseline fixed during each positive run and confirms a rise when the sum crosses the detection threshold and the run contains at least four readings. The display marks the first reading of the confirmed run and links it to the most recent logged hydration event within the preceding hour when an entry exists.

Automatic hydration event logging

A water bottle uses a load cell and a tilt sensor to log drinking events while the interstitial glucose sensor streams readings to a handheld display. The bottle records an event when a detected tilt is followed by an upright, stable mass at least 30 grams below the stable mass measured before the tilt. The handheld device identifies sustained rises in the glucose stream and searches the bottle log for an event in the 30 minutes before each onset. It marks the onset on the glucose plot and shows the timestamp and measured mass change of the closest preceding event when one exists.

Specific version of a part

Readings entered by hand

The sensor stores timestamped readings and presents them on its local readout. A person transcribes the timestamps and glucose values using a numeric keypad, and the separate computing device analyzes consecutive entries for rising episodes.

Enzyme coated subcutaneous electrode

A flexible subcutaneous filament carries a platinum working electrode coated with immobilized glucose oxidase and a glucose diffusion membrane. A potentiostat measures the current from hydrogen peroxide oxidation, and stored calibration coefficients convert the current to an interstitial glucose concentration.

Active matrix touch display

A 480-by-320-pixel active matrix liquid crystal panel shows the glucose trace and a vertical marker at episode onset. A capacitive touch layer lets the viewer select the marker to open the associated behavior record.

Short-range radio packet receiver

A 2.4-gigahertz receiver accepts a packet containing a sample sequence number, a timestamp, and a glucose value every five minutes. The receiver verifies a cyclic redundancy check and passes accepted packets to the processor, which uses sequence numbers to identify gaps.

Slope and duration detection

The processor fits a straight line to four consecutive five-minute glucose readings and flags a rise when the fitted slope reaches 1 milligram per deciliter per minute and the last reading exceeds the first by at least 15 milligrams per deciliter. It marks the first reading as onset and displays the nearest logged meal in the preceding 60 minutes when one is present.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2012/0010600 A1
Published
Jan 12, 2012
Filed
Sep 22, 2011
Class
A61M 5/00
Document BUS 8,282,550 B2
Published
Oct 9, 2012
Filed
Jul 29, 2008
Class
A61B 5/00
Claim 1
Document A
Document B
1.1a continuous glucose sensor configured to detect glucose levels in interstitial fluid of the subject; and
A closed-loop system, also called the “artificial pancreas,” consists of three components: a glucose monitoring device such as a continuous glucose monitor (“CGM”) that measures subcutaneous glucose concentration (“SC”); a titrating algorithm to compute the amount of analyte such as insulin and/or glucagon to be delivered; and one or more analyte pumps to deliver computed analyte doses subcutaneously.
A · US 2012/0010600 A1 · ¶ 7
During general operation of the sensor a biological sample (for example, blood or interstitial fluid) or a portion thereof contacts (for example, directly or after passage through one or more domains of the sensing membrane) an enzyme (for example, glucose oxidase); the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the glucose level in the biological sample.
B · US 8,282,550 B2 · ¶ 79
1.2a computing device, comprising: a display;
In general, the integrated receiver 12 includes a single point glucose monitor 14, electronic circuitry that processes data from the continuous glucose sensor 10 and the single point glucose monitor 14, and a user interface 16 that displays glucose data to a user, all of which are described in more detail with reference to FIGS. 4 to 10.
B · US 8,282,550 B2 · ¶ 99
1.3a computing device, comprising: a communication device configured to receive data indicative of the detected glucose levels from the continuous glucose sensor; and
The output of such sensors can be communicated to a hand held device that is used to calculate an appropriate dosage of insulin to be delivered into the blood stream in view of several factors, such as a patient's present glucose level, insulin usage rate, carbohydrates consumed or to be consumed, and exercise, among others.
A · US 2012/0010600 A1 · ¶ 5
Wireless transmissions 18 allow communication between the glucose sensor 10 and the integrated receiver 12, for example, so that the integrated receiver 12 can receive a data stream from the continuous glucose sensor 10.
B · US 8,282,550 B2 · ¶ 99
1.4a computing device, comprising: a processor coupled to the display, the communication device, and a memory, wherein the memory stores instructions that, when executed by the processor, cause the processor to: detect an episode in data indicative of the detected glucose levels, wherein the episode comprises a rise in the detected glucose levels, and wherein the episode comprises a minimum number of detected glucose levels or a minimum duration, output, on the display, a plot of the detected glucose levels over a period of time, and an indication of a start time of the episode, determine an association of the episode with a self-care behavior, wherein the self-care behavior occurs prior to the start time of the episode, and output, on the display, the associated self-care behavior to show the association between the self-care behavior and the episode.
User output can be in the form of a numeric estimated glucose value, an indication of directional trend of glucose concentration, and/or a graphical representation of the estimated glucose data over a period of time, for example.
B · US 8,282,550 B2 · ¶ 201

An empty cell means only that no passage was reproduced there.

Statements in these documents
A system capable of integrating and automating the functions of glucose monitoring and controlled insulin delivery would be useful in assisting patients in maintaining their glucose levels, especially during periods of the day when they are unable to intervene.
A · US 2012/0010600 A1 · ¶ 6
The development, evaluation, and testing of closed-loop systems are time-consuming, costly, and confounded by ethical and regulatory issues.
A · US 2012/0010600 A1 · ¶ 8
Therefore, the use of a continuous device can be cumbersome, particularly when the user is away from home.
B · US 8,282,550 B2 · ¶ 3
A continuous glucose sensor that includes simpler or fewer components than prior art sensors, that is user friendly, that exhibits reduced error within the calibrated sensor values, and/or is less prone to human error is desirable.
B · US 8,282,550 B2 · ¶ 5
Cite aspatent.fyi, US 2026/0354770 A1, claim 1, first published 2026-11-19T03:31:31-05:00, https://patent.fyi/US20260354770/, SHA-256 30bb7938e7093e2000a482366a6c09f25d5537c21d1049ac6ebbdc0d9ccff6d3
First published
Permanent addresshttps://patent.fyi/US20260354770/
Content fingerprint (SHA-256)30bb7938e7093e2000a482366a6c09f25d5537c21d1049ac6ebbdc0d9ccff6d3
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi